SRL
WGS icon

Scientech Research LLC’s GeneDx Holdings WGS Stock Holding History

Scientech Research LLC’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,617
Closed -$675K – 883
2025
Q1 		$675K Buy
+7,617
New +$661K 0.18% 259

Other funds holding WGS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Scientech Research LLC's WGS Position: Q2 2025 in Review

Scientech Research LLC sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 7,617 shares — an estimated $675K sold.

Scientech Research LLC first reported a position in WGS in Q1 2025 and held it in 1 quarter. The position peaked at $675K in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Scientech Research LLC reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Scientech Research LLC sold 7,617 GeneDx Holdings shares in Q2 2025, an estimated $675K.
  • Scientech Research LLC first reported a position in GeneDx Holdings in Q1 2025 and held it in 1 quarter.
  • Scientech Research LLC's GeneDx Holdings position peaked at $675K in Q1 2025.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Scientech Research LLC's 13F filing for Q2 2025, filed 14 Aug 2025.